Ekso Bionics Holdings, Inc. (EKSO)
USD 0.63
(-11.99%)
USD 0.63
(-11.99%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -12.05 Million | -14.68 Million | -11.15 Million | -8.75 Million | -15.77 Million | -22.16 Million |
| Net Income | -15.19 Million | -15.08 Million | -9.76 Million | -15.82 Million | -12.13 Million | -26.99 Million |
| Depreciation & Amortization | 1.69 Million | 887 Thousand | 561 Thousand | 620 Thousand | 690 Thousand | 1.51 Million |
| Deferred income taxes | -7.53 Million | - | -4.11 Million | 2.42 Million | -5.86 Million | -606 Thousand |
| Stock-based compensation | 2.23 Million | 2.73 Million | 2.5 Million | 2.57 Million | 2.39 Million | 3.08 Million |
| Change in working capital | -583 Thousand | -2.58 Million | -468 Thousand | 1.12 Million | -2.01 Million | 530 Thousand |
| Other non-cash items | 7.33 Million | -647 Thousand | 134 Thousand | 319 Thousand | 1.16 Million | 308 Thousand |
| Investing Cash Flow | -157 Thousand | -5.17 Million | -59 Thousand | - | -60 Thousand | -131 Thousand |
| Investments in PPE | -157 Thousand | -194 Thousand | -59 Thousand | - | -60 Thousand | -131 Thousand |
| Acquisitions | - | -5 Million | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -157 Thousand | 19 Thousand | - | - | - | - |
| Financing Cash Flow | 348 Thousand | 176 Thousand | 38.71 Million | 10.7 Million | 19.03 Million | 2.27 Million |
| Debt repayment | -313 Thousand | - | - | -2.79 Million | -2.37 Million | -2.17 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 661 Thousand | 176 Thousand | 37.29 Million | 7.08 Million | 21.18 Million | 4.44 Million |
| Other Financing Activities | -313 Thousand | -176 Thousand | 1.41 Million | 6.41 Million | 228 Thousand | 1000.00 |
| Accounts receivables | -1.2 Million | -67 Thousand | -1.62 Million | 1.75 Million | -1.59 Million | -850 Thousand |
| Accounts payables | -1.3 Million | -102 Thousand | 1.61 Million | -402 Thousand | -1.23 Million | 752 Thousand |
| Inventory | 232 Thousand | -1.4 Million | -752 Thousand | 379 Thousand | 893 Thousand | -1.65 Million |
| Other working capital | 1.7 Million | -1.01 Million | 296 Thousand | -608 Thousand | -82 Thousand | 2.28 Million |
| Cash at beginning of period | 20.52 Million | 40.4 Million | 12.86 Million | 10.87 Million | 7.65 Million | 27.81 Million |
| Cash at end of period | 8.63 Million | 20.52 Million | 40.4 Million | 12.86 Million | 10.87 Million | 7.65 Million |
| Capital Expenditure | -157 Thousand | -194 Thousand | -59 Thousand | - | -60 Thousand | -131 Thousand |
| Effect of forex changes on cash | -24 Thousand | -18 Thousand | 47 Thousand | 41 Thousand | 10 Thousand | -135 Thousand |
| Net cash flow / Change in cash | -11.88 Million | -19.88 Million | 27.54 Million | 1.99 Million | 3.21 Million | -20.15 Million |
| Free Cash Flow | -12.21 Million | -14.88 Million | -11.21 Million | -8.75 Million | -15.83 Million | -22.29 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2.07 Million | -2.41 Million | -3.42 Million | -15.19 Million | -3.21 Million | -3.36 Million |
| Depreciation & Amortization | 407 Thousand | 397 Thousand | 406 Thousand | 1.69 Million | 675 Thousand | 342 Thousand |
| Deferred income taxes | - | - | - | -7.53 Million | -382 Thousand | 382 Thousand |
| Stock-based compensation | 470 Thousand | 368 Thousand | 405 Thousand | 2.23 Million | 553 Thousand | 526 Thousand |
| Change in working capital | -468 Thousand | -1.07 Million | -952 Thousand | -583 Thousand | 914 Thousand | -1.32 Million |
| Other non-cash items | -614 Thousand | 1.71 Million | 1.58 Million | 7.33 Million | -130 Thousand | 82 Thousand |
| Investing Cash Flow | -8000.00 | - | -8000.00 | -157 Thousand | -43 Thousand | -17 Thousand |
| Investments in PPE | -8000.00 | - | -8000.00 | -157 Thousand | -43 Thousand | -17 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -16 Thousand | - | - | -157 Thousand | -157 Thousand | - |
| Financing Cash Flow | 4.69 Million | -265 Thousand | 3.65 Million | 348 Thousand | 348 Thousand | - |
| Debt repayment | -313 Thousand | -312 Thousand | -313 Thousand | -313 Thousand | -313 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 5 Million | 47 Thousand | 3.97 Million | 661 Thousand | 661 Thousand | - |
| Other Financing Activities | 312 Thousand | 47 Thousand | 3.97 Million | -313 Thousand | -313 Thousand | - |
| Accounts receivables | -398 Thousand | -815 Thousand | -214 Thousand | -1.2 Million | 140 Thousand | -830 Thousand |
| Accounts payables | -322 Thousand | 249 Thousand | 32 Thousand | -1.3 Million | -660 Thousand | -634 Thousand |
| Inventory | -71 Thousand | 71 Thousand | -80 Thousand | 232 Thousand | 394 Thousand | 121 Thousand |
| Other working capital | 323 Thousand | -582 Thousand | -690 Thousand | 1.7 Million | 1.04 Million | 23 Thousand |
| Cash at beginning of period | 5.88 Million | 8.79 Million | 8.63 Million | 20.52 Million | 9.93 Million | 13.3 Million |
| Cash at end of period | 8.29 Million | 5.88 Million | 8.79 Million | 8.63 Million | 8.63 Million | 9.93 Million |
| Capital Expenditure | -8000.00 | - | -8000.00 | -157 Thousand | -43 Thousand | -17 Thousand |
| Effect of forex changes on cash | 1000.00 | 21 Thousand | -22 Thousand | -24 Thousand | -20 Thousand | - |
| Net cash flow / Change in cash | 2.4 Million | -2.91 Million | 161 Thousand | -11.88 Million | -1.29 Million | -3.37 Million |
| Free Cash Flow | -2.28 Million | -2.67 Million | -3.47 Million | -12.21 Million | -1.62 Million | -3.37 Million |
688668
GTSI
TEGY
000885
FMCCP
7874